Background
The relationship between osteoporosis and intervertebral disc (IVD) degeneration remains controversial. Novel quantitative Dixon (Q‐Dixon) and GRAPPATINI T2 mapping techniques have shown potential for evaluating the biochemical components of the spine.
Purpose
To investigate the correlation of osteoporosis with IVD degeneration in postmenopausal women.
Study Type
Prospective.
Subjects
A total of 105 postmenopausal females (mean age, 65 years; mean body mass index, 26 kg/m2).
Field Strength/Sequence
3 T; sagittal; 6‐echo Q‐Dixon, multiecho spin‐echo GRAPPATINI T2 mapping, turbo spin echo (TSE) T1‐weighted and TSE T2‐weighted sequences.
Assessment
The subjects were divided into normal (N = 47), osteopenia (N = 28), and osteoporosis (N = 30) groups according to quantitative computed tomography examination. The Pfirrmann grade of each IVD was obtained. Region of interest analysis was performed separately by two radiologists (X.L., with 10 years of experience, and S.C., with 20 years of experience) on a fat fraction map and T2 map to calculate the bone marrow fat fraction (BMFF) from the L1 to L5 vertebrae and the T2 values of each adjacent IVD separately.
Statistical Tests
One‐way analysis of variance, post‐hoc comparisons, and Kruskal–Wallis H tests were performed to evaluate the differences in the magnetic resonance imaging parameters between the groups. The relationships between BMFF and the IVD features were analyzed using the Spearman correlation analysis and linear regression models.
Results
There were significant differences in BMFF among the three groups. The osteoporosis group had higher BMFF values (64.5 ± 5.9%). No significant correlation was found between BMFF and Pfirrmann grade (r = 0.251, P = 0.06). BMFF was significantly negatively correlated with the T2 of the adjacent IVD from L1 to L3 (r = −0.731; r = −0.637; r = −0.547), while significant weak correlations were found at the L4 to L5 levels (r = −0.337; r = −0.278).
Data Conclusion
This study demonstrated that osteoporosis is associated with IVD degeneration.
Level of Evidence
2
Technical Efficacy
Stage 4